Intratumoural administration and tumour tissue targeting of cancer immunotherapies

Immune-checkpoint inhibitors and chimeric antigen receptor (CAR) T cells are revolutionizing oncology and haematology practice. With these and other immunotherapies, however, systemic biodistribution raises safety issues, potentially requiring the use of suboptimal doses or even precluding their cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Melero, Ignacio, Castanon, Eduardo, Alvarez, Maite, Champiat, Stephane, Marabelle, Aurelien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130796/
https://www.ncbi.nlm.nih.gov/pubmed/34006998
http://dx.doi.org/10.1038/s41571-021-00507-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130796/
https://www.ncbi.nlm.nih.gov/pubmed/34006998
http://dx.doi.org/10.1038/s41571-021-00507-y

Ejemplares similares